/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Journey Medical Corp

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$7.67 0.0378(3.78%) DERM at 04 Dec 2025 04:29 PM Drug Manufacturers - Specialty & Generic
Lowest Today 7.32
Highest Today 7.67
Today’s Open 7.32
Prev. Close 7.41
52 Week High 9.40
52 Week Low 3.54
Day’s Range: Low 7.32 High 7.67
52-Week Range: Low 3.54 High 9.40
1 day return -
1 Week return -4.59
1 month return -14.71
3 month return +9.16
6 month return +2.4
1 year return +38.37
3 year return +343.93
5 year return -
10 year return -

Institutional Holdings

TANG CAPITAL MANAGEMENT LLC 7.05

Wasatch Advisors LP 4.38

Vanguard Group Inc 2.15

BlackRock Inc 2.07

Wasatch Micro Cap Value 1.98

Wasatch Micro Cap Value Composite 1.61

Geode Capital Management, LLC 1.00

Vanguard Total Stock Mkt Idx Inv 0.96

Renaissance Technologies Corp 0.93

Essex Investment Management Company, LLC 0.87

iShares Russell 2000 ETF 0.80

American Financial Group Inc 0.68

UBS Group AG 0.60

Vanguard Institutional Extnd Mkt Idx Tr 0.55

Fidelity Small Cap Index 0.47

State Street Corp 0.44

iShares Russell 2000 Growth ETF 0.42

IMC US Ultra Micro Cap 0.39

The Informed Momentum Company (formerly EAM Investors) 0.36

Opaleye Management Inc 0.36

Northern Trust Corp 0.32

Pleiades Small Cap Equity A 0.32

1290 Essex Small Cap Growth I 0.30

Envestnet Asset Management Inc 0.27

Legato Capital Management LLC 0.26

Geneos Wealth Management Inc 0.24

Fidelity Extended Market Index 0.24

Vanguard Russell 2000 ETF 0.22

Integrated Wealth Concepts LLC 0.21

Morgan Stanley - Brokerage Accounts 0.20

State St Russell Sm Cap® Indx SL Cl I 0.16

Atria Investments LLC 0.14

Gladstone Institutional Advisory LLC 0.12

Schwab Small Cap Index 0.12

NT R2000 Index Fund - NL 0.11

iShares Micro-Cap ETF 0.11

Fidelity Total Market Index 0.09

NT R2000 Index Fund - DC - NL - 3 0.09

Fidelity Series Total Market Index 0.08

iShares Russell 2000 Small-Cap Idx Instl 0.08

Market Status

Strong Buy: 3

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 201.08 M

PB Ratio 8.0052

PE Ratio 0.0

Enterprise Value 207.67 M

Total Assets 80.24 M

Volume 288209

Company Financials

Annual Revenue FY23:79890000 79.9M, FY22:73669000 73.7M, FY21:63134000 63.1M, FY20:44531000 44.5M, FY19:34921000 34.9M

Annual Profit FY23:51527000 51.5M, FY22:42894000 42.9M, FY21:31050000 31.1M, FY20:29937000 29.9M, FY19:24389000 24.4M

Annual Net worth FY23:-12352000 -12.4M, FY22:-29628000 -29.6M, FY21:-43994000 -44.0M, FY20:5283000 5.3M, FY19:3625000 3.6M

Quarterly Revenue Q3/2025:17631000 17.6M, Q2/2025:15009000 15.0M, Q1/2025:13139000 13.1M, Q3/2024:14629000 14.6M, Q2/2024:14855000 14.9M

Quarterly Profit Q3/2025:11876000 11.9M, Q2/2025:9006000 9.0M, Q1/2025:8349000 8.3M, Q3/2024:9344000 9.3M, Q2/2024:8314000 8.3M

Quarterly Net worth Q3/2025:-2315000 -2.3M, Q2/2025:-3796000 -3.8M, Q1/2025:-4073000 -4.1M, Q3/2024:-2390000 -2.4M, Q2/2024:-3361000 -3.4M

Fund house & investment objective

Company Information Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Organisation Drug Manufacturers - Specialty & Generic

Employees 41

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Claude Maraoui

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow